COMMUNIQUÉS West-GlobeNewswire

-
Canada House Wellness Group Reports Second Quarter Fiscal Year 2019 Results
14/12/2018 -
Genmab Announces Submission of Supplemental New Drug Application for Daratumumab in Front Line Multiple Myeloma in Japan
14/12/2018 -
Extendicare Announces December 2018 Dividend of C$0.04 per Share
14/12/2018 -
Teligent, Inc. Executes $120 Million Financing Agreement
14/12/2018 -
PotNetwork Holdings, Inc. Withdraws Form 10
13/12/2018 -
Axovant Sciences Announces Public Offering of Common Shares
13/12/2018 -
Agile Therapeutics, Inc. Meets With FDA on Comparative Wear Study of Twirla® and Xulane®
13/12/2018 -
Ziopharm Oncology Promotes Dr. David Mauney to President
13/12/2018 -
Conformis Announces Strategic Actions to Reach Profitability and Reduce Debt
13/12/2018 -
OrthoPediatrics Corp. Announces Full-Scale U.S. Launch of Small Stature Scoliosis System
13/12/2018 -
National Institute on Drug Abuse Presents Data on Trevena’s TRV734 at the 57th Annual Meeting of the American College of Neuropsychopharmacology
13/12/2018 -
Axovant Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from University of Massachusetts Medical School
13/12/2018 -
Pediapharm Announces Name Change, Consolidation and Debenture Repayment
13/12/2018 -
Algae Biomass Organization Bringing 2019 Algae Biomass Summit to Orlando, Florida
13/12/2018 -
Diffusion Pharmaceuticals Announces 1-for-15 Reverse Stock Split As Part Of NASDAQ Compliance Plan
13/12/2018 -
Retrotope Announces First Dosing of RT001 in patients with Infantile Neuroaxonal Dystrophy (INAD)
13/12/2018 -
Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi
13/12/2018 -
Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M
13/12/2018 -
Reminder- Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease Tomorrow
13/12/2018
Pages